Reports + Research
UC San Diego Health Uses 3D Technology to Fix Previously Inoperable Aortic Aneurysms
A thoracoabdominal aortic aneurysm is an aneurysm that balloons out of the aorta, which causes aortic wall weakening. Traditionally, surgeons need to use contrast dyes to place a stent in the aneurysm, but these dyes can cause post-surgery kidney problems in up to 25 percent of patients. UC San Diego Health is employing a new technology, called Dynamic Morphology Correction, to decrease the amount of dye used and surgical time. According to a statement, “the technology builds a 3D model of the aneurysm and surrounding vessels using a pre-operative CT scan,” and fuses that with a real-time image during the operation.
Turning Point Therapeutics Raises More Than $200 Million in Public Offering
In April, Turning Point raised more than $190 million in its initial public offering, and now the public markets have provided more than $200 million in capital to help the company continue to build a pipeline of next generation, tyrosine kinase inhibitor, cancer drugs. This recent financing comes on the heels of positive Phase 1/2 clinical trial data of the company’s lead drug candidate, repotrectinib, which is in clinical trials to treat non-small cell lung cancer.
Connect to Honor Four Local Innovation Leaders at Annual Awards
At Connect’s 32nd annual Innovation Awards, Connect w/ San Diego Venture Group (SDVG) will induct David Hale into the Connect Entrepreneur Hall of Fame. Connect will also honor Taner Halicioglu and Dr. Carol Gallagher with Duane Roth Distinguished Contribution Awards and Dr. Mary Walshok with the William W. Otterson Award for Advancing Entrepreneurship and Innovation. Each of these leaders have made “invaluable contributions” to promote innovation for the San Diego life sciences and tech ecosystem.
Read + Listen
POW: Podcast of the Week
Jeff Stein, CEO of Cidara Therapeutics, talks with mendelspod.com about a universal flu vaccine.
It’s Happening Here
September 24:
JLABS San Diego is hosting serial entrepreneur Michael Gilman on September 24 at 8am for a conversation about starting up and getting bought out.
September 24-25:
BIOCOM Life Science HR Conference is taking place September 24-25 at The Alexandria at Torrey Pines.
September 25:
On September 25, Meet with BARDA at Green Acre, Campus Point from 3:30pm-7pm
Tags: Biotech, Biotech Briefing, Innovation, investing, Medical Research, Venture Funding